Skip to content
The Policy VaultThe Policy Vault

Lanreotide subcutaneous injection – CiplaMedica

Small bowel bleeds/angiodysplasia related bleeding

Initial criteria

  • Patient has chronic, recurrent gastrointestinal bleeds lasting ≥ 3 months
  • Medication is prescribed by or in consultation with a gastroenterologist

Approval duration

6 months